Surgery for non-small cell lung cancer: Systematic review and meta-analysis of randomised controlled trials

Thorax

Volumn 61, Issue 7, 2006, Pages 597-603

  Wright, G ^a   Manser, R L ^a,b   Byrnes, G ^c   Hart, D ^a   Campbell, D A ^d  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA SYNTHESIS; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MEDIASTINUM LYMPH NODE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33745870113     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.051995     Document Type: Review

References (36)

1. Reif M, Socinski MA, Rivera MP. Evidence-based medicine in the treatment of non-small cell lung cancer. Clin Chest Med 2000;21:107-20.
2. Scott W, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest 2003;123(Suppl 1):188-201S.
3. Smythe W. Treatment of stage I non-small cell lung carcinoma. Chest 2003;123(Suppl 1):181-7S.
4. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992;101:1013-8.
5. Sobue T, Suzuki T, Matsuda M, et al. Survival for clinical stage I lung cancer not surgically treated: comparison between screen-detected and symptom-detected cases. Cancer 1992;69:685-92.
6. Lederle F, Niewoehner DE. Lung cancer surgery: a critical review of the evidence. Arch Intern Med 1994;154:2397-401.
7. Jones D, Detterbeck FC. Surgery for stage I non-small cell lung cancer. In: Detterbeck F, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and treatment of lung cancer- an evidence based guide. Philadelphia: W B Sounders, 2001:177-90.
8. Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer (Cochrane Review). In:The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, 2005.
9. Clarke M, Oxman AD, eds. Cochrane reviewers' handbook 4.1. Oxford, UK: The Cochrane Collaboration, 2000.
10. Jadad A, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
11. Montori V, Guyatt GH. Intention-to-treat principle. Can Med Assoc J 2001;165:1339-41.
12. Fergusson D, Aaron SD, Guyatt G, et al. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4.
13. Izbicki J, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998;227:138-44.
14. Sugi K, Nawata K, Fujita N, et al. Systematic Lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-5.
15. Wu Y-I, Huang Z-F, Wang S-Y, et al. A randomised trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
16. Stathopoulos G, Papakostas P, Malamos NA, et al. Chemo-radiotherapy versus chemo-surgery in stage IIIA non-small cell lung cancer. Oncol Rep 1996;3:673-6.
17. Johnstone D, Byhardt RW, Ettinger D, et al. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer with spread to mediastinal lymph nodes (N2). Final report of RTOG 89-01. Int J Radiat Oncol Biol Phys 2002;54:365-9.
18. Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
19. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Stat Med 1991;10:1665-77.
20. Albain K, Scott CB, Rusch VR, et al. Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by resection for stage IIIA (pN2) NSCLC. Lung Cancer 2003;41(Suppl 2):S4.
21. Izbicki J, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumour staging in lung cancer. Ann Thorac Surg 1995;59:209-14.
22. Ginsberg R, Rubinstein LV, for the Lung Cancer Study Group. Randomised trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer. Ann Thorac Surg 1995;60:615-23.
23. Rubinstein L, Ginsberg RJ. Lobectomy versus limited resection in T1NO lung cancer. Ann Thorac Surg 1996;62:1249-50.
24. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long term prognosis in patients with clinical stage 1A lung cancer. World J Surg 2000;24:27-31.
25. Morrison R, Deeley TJ, Cleland WP. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1963;1:683-4.
26. Shepherd F, Johnston MR, Payne D, et al. Randomised study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Br J Cancer 1998;78:683-5.
27. Warram J, on behalf of collaborating investigators. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial (a collaborative study). Cancer 1975;36:914-25.
28. Warram J, on behalf of collaborating investigators. Preoperative irradiation of cancer of the lung: preliminary report of a therapeutic trial (a collaborative study). Cancer 1909;23:419-29.
29. Splinter T, van Schil PE, Kramer GWPM, et al. Randomised trial of surgery versus radiotherapy in patients with stage IIIA (N2) non-small cell lung cancer after response to induction chemotherapy (EORTC 08941). Clin Lung Cancer 2000;2:69-72.
30. Keller S. Complete mediastinal lymph node dissection - does it make a difference? Lung Cancer 2002;36:7-8.
31. Allen M, for the American College of Surgeons Oncology Group (Thoracic Organ Site Committee). Randomised trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in patients with N0 or N1 (less than hilar) non-small cell lung cancer. Available at http://www.acosog.org/studies/synopses/Z0030_Synopsis.pdf (accessed October 2004).
32. Naruke T, Suemasu K, Ishikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 1976;71:279-85.
33. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037.
34. Feinstein A, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
35. Bach P, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181-8.
36. Kiser A, Detterbeck FC. General aspects of surgical treatment. In: Detterbeck F, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and treatment of lung cancer: an evidence based guide. Philadelphia: WB Sounders, 2001:133-47.